Cargando…

Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer

PURPOSE: To evaluate the risk factors associated with loco-regional failure after surgical resection and to identify the subgroup that can obtain benefits from adjuvant radiotherapy (RT). MATERIALS AND METHODS: We identified patients treated with surgical resection for resectable pancreatic cancer a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun Ju, Lee, Woo Jung, Kang, Chang Moo, Hwang, Ho Kyoung, Bang, Seung Min, Song, Si Young, Seong, Jinsil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917092/ https://www.ncbi.nlm.nih.gov/pubmed/27332708 http://dx.doi.org/10.1371/journal.pone.0157196

Ejemplares similares

Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis
por: Oh, Tak Geun, et al.
Publicado: (2014)

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
por: Lee, Jin Ho, et al.
Publicado: (2015)

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy
por: Dahmani, Wafa, et al.
Publicado: (2023)

Identification of an N staging system that predicts oncologic outcome in resected left-sided pancreatic cancer
por: Kim, Sung Hyun, et al.
Publicado: (2016)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

Pancreas club international joint symposium on pancreatic cancer 2012, Kyoto: down staging chemo±radiotherapy for borderline resectable pancreatic cancer
por: Kang, Chang Moo, et al.
Publicado: (2013)

Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
por: Yoon, Min Sung, et al.
Publicado: (2022)

Intraoperative Transfusion is Independently Associated with a Worse Prognosis in Resected Pancreatic Cancer—A Retrospective Cohort Analysis
por: Kim, Si Youn, et al.
Publicado: (2020)

Axillary nodal metastasis and resection margins as predictors of Loco Regional Recurrence in Breast Cancer Patients
por: Ayandipo, OO, et al.
Publicado: (2022)

Clinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma
por: CHOI, SUNG HOON, et al.
Publicado: (2013)

Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer
por: Kang, Chang Moo, et al.
Publicado: (2016)

Clinically determined type of (18)F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer
por: Chong, Jae Uk, et al.
Publicado: (2017)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
por: Yoon, Ja Kyung, et al.
Publicado: (2022)

Potential Impact of Phellinus linteus on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
por: Lee, Sung Hwan, et al.
Publicado: (2018)

Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis
por: Lee, Sung Hwan, et al.
Publicado: (2019)

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
por: Lee, Sung Hwan, et al.
Publicado: (2015)

Pancreatic hamartoma diagnosed after surgical resection
por: Kim, Ho-Hyun, et al.
Publicado: (2012)

Preoperative Volume-Based PET Parameter, MTV(2.5), as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer
por: Kang, Chang Moo, et al.
Publicado: (2016)

Surgical resection of metastasis to the pancreas
por: You, Dong Do, et al.
Publicado: (2011)

The survival impact of surgical waiting time in patients with resectable pancreatic head cancer
por: Seo, Hye Kyoung, et al.
Publicado: (2018)

Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation
por: Park, Ji Hoon, et al.
Publicado: (2022)

Surgical resectability of pancreatic adenocarcinoma: CTA
por: Wong, Jimmie C., et al.
Publicado: (2009)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments
por: Ranieri, Girolamo, et al.
Publicado: (2020)

Preoperative Clinical and Computed Tomography (CT)-Based Nomogram to Predict Oncologic Outcomes in Patients with Pancreatic Head Cancer Resected with Curative Intent: A Retrospective Study
por: Hwang, Shin Hye, et al.
Publicado: (2019)

Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma
por: Rho, Seoung Yoon, et al.
Publicado: (2019)

Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer
por: Hwang, Ho Kyoung, et al.
Publicado: (2016)

Yonsei Criteria, a Potential Linkage to Intratumoral Foxp3(+)/CD8(+) Ratio for the Prediction of Oncologic Outcomes in Resected Left-Sided Pancreatic Cancer
por: Hwang, Ho Kyoung, et al.
Publicado: (2020)

Use of Articaine in loco-regional anesthesia for day care surgical procedures
por: Bajwa, Sukhminder Jit Singh, et al.
Publicado: (2012)

Local recurrence after curative resection for rectal carcinoma: The role of surgical resection
por: Yun, Jung-A, et al.
Publicado: (2016)

Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma
por: Yoon, Kyoung Won, et al.
Publicado: (2011)

The role of surgical resection before palliative chemotherapy in advanced gastric cancer
por: Choi, Yong Won, et al.
Publicado: (2019)

What Is the Next in Developing Model to Predict Survival Outcomes of Resected Pancreatic Cancer?
por: Kang, Chang Moo
Publicado: (2021)

Survival benefits of surgical resection in recurrent cholangiocarcinoma
por: Song, Sun Choon, et al.
Publicado: (2011)

Laparoscopic resection of retroperitoneal benign neurilemmoma
por: Ji, Jung Hwan, et al.
Publicado: (2017)

A nomogram to preoperatively predict 1-year disease-specific survival in resected pancreatic cancer following neoadjuvant chemoradiation therapy
por: Hwang, Ho Kyoung, et al.
Publicado: (2020)

Loco-regional intervention for hepatocellular carcinoma
por: Lau, Wan Yee, et al.
Publicado: (2019)

Surgical Resection of Thoracic Duct Lymphangioma
por: Bok, Jin San, et al.
Publicado: (2014)

Pancreatic Resections in Renal Failure Patients: Is It Worth the Risk?
por: Norman, K. S., et al.
Publicado: (2014)

Editorial: Improving surgical outcomes after pancreatic resection
por: Caputo, Damiano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_asap7k45n9k1gn9i2d1vashlqe